BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 31426611)

  • 1. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives.
    Zahan T; Das PK; Akter SF; Habib R; Rahman MH; Karim MR; Islam F
    Anticancer Agents Med Chem; 2020; 20(18):2190-2206. PubMed ID: 32748758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells and chemoresistance: The smartest survives the raid.
    Zhao J
    Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
    Madden EC; Gorman AM; Logue SE; Samali A
    Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies.
    Wang H; Cui G; Yu B; Sun M; Yang H
    Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.
    Brown Y; Hua S; Tanwar PS
    Int J Biochem Cell Biol; 2019 Apr; 109():90-104. PubMed ID: 30743057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.